Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 13-16 September 2021
https://www.ema.europa.eu/en/news/meeting-highlights-committee-medicinal-products-human-use-chmp-13-16-september-2021
European Medicines Agency post-authorisation procedural advice for users of the centralised procedure
https://www.ema.europa.eu/en/documents/regulatory-procedural-guideline/european-medicines-agency-post-authorisation-procedural-advice-users-centralised-procedure_en.pdf
Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 30 August – 2 September 2021
https://www.ema.europa.eu/en/news/meeting-highlights-pharmacovigilance-risk-assessment-committee-prac-30-august-2-september-2021
Artificial intelligence in medicine regulation – EMA
https://www.ema.europa.eu/en/news/artificial-intelligence-medicine-regulation
